TNDM — Tandem Diabetes Care Balance Sheet
0.000.00%
Last trade - 00:00
- $2.82bn
- $2.70bn
- $747.72m
- 68
- 20
- 87
- 60
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 176 | 485 | 624 | 617 | 468 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 46.6 | 82.2 | 111 | 115 | 106 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 276 | 637 | 812 | 850 | 748 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 48.5 | 69.8 | 77.9 | 179 | 164 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 326 | 716 | 905 | 1,053 | 953 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 99.4 | 104 | 132 | 165 | 195 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 131 | 350 | 472 | 613 | 639 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 195 | 366 | 433 | 440 | 314 |
Total Liabilities & Shareholders' Equity | 326 | 716 | 905 | 1,053 | 953 |
Total Common Shares Outstanding |